chlorpromazine has been researched along with 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6h-dibenzo(b,d)pyran-1-ol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arendsen, D; Dodge, P; Dren, A; Dunnigan, D; Hallas, R; Hwang, K; Kyncl, J; Lee, YH; Plotnikoff, N; Winn, M; Young, P; Zaugg, H | 1 |
1 other study(ies) available for chlorpromazine and 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6h-dibenzo(b,d)pyran-1-ol
| Article | Year |
|---|---|
Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains.
Topics: Aggression; Analgesics; Animals; Anticonvulsants; Antidepressive Agents; Antidiarrheals; Antihypertensive Agents; Ataxia; Blood Pressure; Cannabis; Cats; Dogs; Dronabinol; Gastric Mucosa; Haplorhini; Humans; Hypnotics and Sedatives; Male; Mice; Motor Activity; Rats; Sleep; Stomach Ulcer; Structure-Activity Relationship; Tranquilizing Agents | 1976 |